Your browser is no longer supported. Please, upgrade your browser.
LCI Lannett Company, Inc. daily Stock Chart
Lannett Company, Inc.
Index- P/E- EPS (ttm)-7.31 Insider Own6.00% Shs Outstand41.01M Perf Week-1.52%
Market Cap239.09M Forward P/E6.48 EPS next Y0.90 Insider Trans1.95% Shs Float27.81M Perf Month6.39%
Income-273.90M PEG- EPS next Q0.21 Inst Own86.63% Short Float75.01% Perf Quarter-27.58%
Sales692.50M P/S0.35 EPS this Y-29.70% Inst Trans0.16% Short Ratio18.79 Perf Half Y-24.97%
Book/sh8.97 P/B0.65 EPS next Y-58.79% ROA-20.50% Target Price8.88 Perf Year-59.09%
Cash/sh- P/C- EPS next 5Y15.00% ROE-70.00% 52W Range3.33 - 14.20 Perf YTD17.54%
Dividend- P/FCF1.43 EPS past 5Y16.20% ROI8.10% 52W High-59.79% Beta2.39
Dividend %- Quick Ratio2.10 Sales past 5Y35.30% Gross Margin37.70% 52W Low71.47% ATR0.31
Employees1251 Current Ratio2.90 Sales Q/Q-0.90% Oper. Margin-38.10% RSI (14)45.39 Volatility4.56% 5.59%
OptionableYes Debt/Eq2.29 EPS Q/Q137.10% Profit Margin-39.80% Rel Volume0.92 Prev Close5.83
ShortableYes LT Debt/Eq2.10 EarningsAug 05 AMC Payout- Avg Volume1.11M Price5.71
Recom3.00 SMA20-2.21% SMA50-4.52% SMA200-10.79% Volume133,473 Change-2.06%
Mar-20-19Initiated SunTrust Hold
Aug-20-18Downgrade ROTH Capital Buy → Neutral
Aug-20-18Downgrade Raymond James Outperform → Mkt Perform
Jan-24-18Initiated Goldman Neutral
Jun-29-16Initiated Deutsche Bank Hold $26
Mar-24-16Downgrade Canaccord Genuity Buy → Sell $28 → $18
Feb-04-16Upgrade Craig Hallum Hold → Buy
Nov-05-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Reiterated ROTH Capital Buy $61 → $68
Jul-21-15Initiated Susquehanna Positive
Feb-05-15Reiterated ROTH Capital Buy $54 → $61
Nov-24-14Reiterated ROTH Capital Buy $66 → $60
Nov-04-14Reiterated ROTH Capital Buy $53 → $66
Nov-04-14Reiterated Canaccord Genuity Buy $55 → $73
Nov-04-14Downgrade Oppenheimer Outperform → Perform $53
Oct-13-14Reiterated Oppenheimer Outperform $51 → $53
Jul-15-14Reiterated Oppenheimer Outperform $49 → $52
May-06-14Resumed Canaccord Genuity Buy $55
Feb-10-14Reiterated Canaccord Genuity Buy $29 → $55
Feb-07-14Reiterated Oppenheimer Outperform $41 → $45
Jul-08-19 06:52AM  Lannett Enters Into Distribution Agreement For Levothyroxine PR Newswire
Jul-03-19 12:02PM  FDA rules in favor of Lannett in dispute over cocaine product American City Business Journals
06:52AM  FDA Clears Path For The Continuing Review Of Lannett Company's New Drug Application PR Newswire
Jun-28-19 06:10PM  Heres What Hedge Funds Think About Lannett Company, Inc. (LCI) Insider Monkey
06:54AM  Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch PR Newswire
Jun-18-19 06:52AM  Lannett Launches Aspirin And Extended-Release Dipyridamole Capsules PR Newswire
Jun-12-19 06:52AM  Lannett To Participate At Two Investor Conferences In June PR Newswire
Jun-05-19 02:14PM  Lannett initiates human testing of biosimilar insulin product American City Business Journals
06:52AM  Lannett Announces Initiation Of Human Clinical Trial Of Biosimilar Insulin Glargine Versus Us Lantus® PR Newswire
May-30-19 07:07PM  Lifshitz & Miller LLP Announces Investigation of A.O. Smith Corporation, Cray Inc., electroCore, Inc., Fred's Inc., Intersect ENT, Inc., Jumia Technologies AG, Lannett Company Inc., and Zayo Group Holdings, Inc. PR Newswire
May-29-19 06:54AM  Lannett Commences Marketing Generic Concerta® PR Newswire
May-24-19 06:52AM  Lannett Announces CFO Retirement PR Newswire -7.06%
May-23-19 04:08PM  (LCI) Alert: Johnson Fistel, LLP Announces Investigation of Lannett Company, Inc.; Long Term Investors Encouraged to Contact Firm PR Newswire
06:52AM  Lannett Appoints Melissa V. Rewolinski, PhD, To Board Of Directors PR Newswire
May-21-19 09:00AM  Haeggquist & Eck Investigates Conspiracy to Fix Prices on Generic Drugs by Lannett Officers and Directors Business Wire
06:52AM  Lannett Purchases Additional $30.5 Million Of Term A Loans PR Newswire
May-20-19 09:30AM  Is Lannett Co (LCI) Outperforming Other Medical Stocks This Year? Zacks
May-17-19 07:47PM  Robbins Arroyo LLP: Shareholder Class Action Against Lannett Company (LCI) Survives Motion to Dismiss Business Wire
08:52AM  Implied Volatility Surging for Lannett (LCI) Stock Options Zacks
May-16-19 07:42PM  Bragar Eagel & Squire, P.C. is Investigating Lannett Company, Inc. (NYSE: LCI) on Behalf of Lannett Stockholders and Encourages Lannett Investors to Contact the Firm GlobeNewswire
11:09AM  Top Ranked Value Stocks to Buy for May 16th Zacks
06:52AM  Lannett Begins Marketing Generic Adderall® PR Newswire
May-14-19 10:17AM  Here's Why Generic-Drug Manufacturers Were Down Monday Motley Fool
May-13-19 05:49PM  LANNETT INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lannett Company, Inc. To Contact The Firm PR Newswire -19.10%
May-10-19 01:50AM  Edited Transcript of LCI earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-08-19 12:03PM  Lannett gets notice that probe into alleged generic drug price-fixing may widen American City Business Journals -6.38%
May-07-19 04:17PM  SHAREHOLDER ALERT: Investigation of Lannett Announced by Holzer & Holzer, LLC Business Wire -15.42%
12:48PM  Here's Why Lannett Company Stock Is Collapsing Today Motley Fool
May-06-19 08:55PM  Lannett Inc (LCI) Q3 2019 Earnings Call Transcript Motley Fool +6.32%
07:45PM  Lannett (LCI) Surpasses Q3 Earnings and Revenue Estimates Zacks
06:40PM  Lannett: Fiscal 3Q Earnings Snapshot Associated Press
04:15PM  Lannett Announces Fiscal 2019 Third-Quarter Financial Results; Raises Guidance For Fiscal 2019 PR Newswire
09:18AM  Lannett Q3 Earnings Preview Benzinga
May-02-19 09:30AM  Is Lannett Co (LCI) Stock Outpacing Its Medical Peers This Year? Zacks
Apr-30-19 12:23PM  Lannett to launch generic ADHD drug this quarter American City Business Journals
06:52AM  Lannett To Launch Generic Concerta®, AB-rated Methylphenidate Hydrochloride ER Tablets PR Newswire
Apr-29-19 10:31AM  Analysts Estimate Lannett (LCI) to Report a Decline in Earnings: What to Look Out for Zacks
09:15AM  Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run? Zacks
06:52AM  Lannett To Report Fiscal 2019 Third-Quarter Financial Results, Host Conference Call On Monday, May 6 PR Newswire
Apr-24-19 04:45PM  Lannett (LCI) to Report Q3 Earnings: What's in the Cards? Zacks
Apr-16-19 03:02PM  Investors Who Bought Lannett Company (NYSE:LCI) Shares Five Years Ago Are Now Down 77% Simply Wall St.
08:43AM  Are Options Traders Betting on a Big Move in Lannett (LCI) Stock? Zacks
Apr-12-19 05:45PM  Lannett (LCI) Gains But Lags Market: What You Should Know Zacks
Apr-08-19 09:30AM  Has Lannett Co (LCI) Outpaced Other Medical Stocks This Year? Zacks
Apr-04-19 05:45PM  Lannett (LCI) Stock Sinks As Market Gains: What You Should Know Zacks
Mar-28-19 05:45PM  Lannett (LCI) Outpaces Stock Market Gains: What You Should Know Zacks
Mar-27-19 06:52AM  Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg PR Newswire +5.36%
Mar-26-19 07:21AM  New Strong Buy Stocks for March 26th Zacks
Mar-21-19 06:54AM  Lannett Purchases $24 Million Of Term Loans In Open Market Transactions PR Newswire
Mar-19-19 12:28PM  Aerie (AERI) Starts Phase II Study on Eye Candidate AR-1105 Zacks
Mar-18-19 11:26AM  Karyopharm Stock Up Even as FDA Delays Selinexor NDA Verdict Zacks
Mar-12-19 09:50AM  Should Value Investors Consider Lannett Company (LCI) Now? Zacks
Mar-11-19 12:44PM  Lannett Rises After Announcing Adderall Distribution Agreement
09:15AM  Late Rally Falls Just Short of Ending Losing Skid Zacks
07:34AM  Lannett shares rise after agreement to sell generic Adderall MarketWatch
06:45AM  Lannett Enters Into Distribution Agreement For Generic Adderall® PR Newswire
Mar-08-19 08:56AM  Endo (ENDP) Soars: Stock Adds 6% in Session Zacks
Mar-04-19 08:43AM  Implied Volatility Surging for Lannett (LCI) Stock Options Zacks -7.53%
Feb-27-19 10:31AM  Top Ranked Value Stocks to Buy for February 27th Zacks
Feb-26-19 11:29AM  Top Ranked Value Stocks to Buy for February 26th Zacks
06:52AM  Lannett To Participate At Two Investor Conferences In March PR Newswire
Feb-22-19 07:55AM  Top Ranked Value Stocks to Buy for February 22nd Zacks
Feb-20-19 10:09AM  Top Ranked Value Stocks to Buy for February 20th Zacks
Feb-15-19 04:29PM  Lannett Company, Inc. -- Moody's announces completion of a periodic review of ratings of Lannett Company, Inc. Moody's +5.03%
Feb-12-19 10:03AM  Top Ranked Value Stocks to Buy for February 12th Zacks +5.29%
Feb-07-19 01:31PM  BMO Capital Markets: Lannett Making Progress With Pipeline, Cost Savings Benzinga
01:12PM  Lannett Hits Key Resistance After Strong Earnings Investopedia
12:57PM  Edited Transcript of LCI earnings conference call or presentation 6-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
06:48AM  Lannett (LCI) Q2 2019 Earnings Conference Call Transcript Motley Fool
Feb-06-19 07:05PM  Lannett (LCI) Q2 Earnings and Revenues Surpass Estimates Zacks
05:59PM  Lannett: Fiscal 2Q Earnings Snapshot Associated Press
04:15PM  Lannett Announces Record Net Sales In The Fiscal 2019 Second-Quarter Financial Results; Raises Guidance For Fiscal 2019 PR Newswire
Jan-30-19 10:31AM  Earnings Preview: Lannett (LCI) Q2 Earnings Expected to Decline Zacks
06:52AM  Lannett To Report Fiscal 2019 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 6 PR Newswire
Jan-22-19 06:52AM  Lannett Enters Into Distribution Agreement For Trientine Hydrochloride Capsules, Launch Imminent PR Newswire
Jan-11-19 05:44PM  Lannett Company, Inc. -- Moody's confirms Lannett's ratings; outlook changed to negative Moody's
Dec-18-18 07:20AM  Recent Analysis Shows MTS, Columbia Sportswear, First Data, Boingo Wireless, Lannett, and Caterpillar Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Dec-17-18 08:54AM  Are Options Traders Betting on a Big Move in Lannett (LCI) Stock? Zacks -5.98%
Dec-13-18 03:26PM  Raymond James: Lannett Emerges From Levothyroxine Woes Benzinga
Dec-11-18 06:52AM  Lannett Announces Amendment To Credit Agreement PR Newswire
Dec-05-18 06:52AM  Lannett To Present At The BMO Capital Markets Prescription For Success Healthcare Conference On December 12 PR Newswire
Nov-23-18 09:30AM  Is Lannett (LCI) a Great Stock for Value Investors? Zacks
Nov-19-18 09:00AM  4 Healthcare Stocks Taking a New Approach to Growth Trends ACCESSWIRE
05:00AM  Edited Transcript of LCI earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-18 09:50AM  Lannett signs $50M distribution deal; stock up 10 percent American City Business Journals
09:45AM  3 Health Care Stocks Making Moves On Monday; Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Lannett Company, ReShape Lifesciences ACCESSWIRE
07:05AM  Lannett signs deal with Amneal Pharma for thryoid treatment, sending stock up 14% premarket MarketWatch
06:54AM  Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine PR Newswire
Nov-09-18 02:33PM  Here's Why Lannett Company Dropped Over 14% Today Motley Fool -8.22%
Nov-08-18 07:07PM  Robbins Arroyo LLP: Lannett Company (LCI) Misled Shareholders According to a Shareholder Complaint Business Wire +35.81%
Nov-07-18 07:50PM  Lannett (LCI) Beats Q1 Earnings and Revenue Estimates Zacks
04:15PM  Lannett Announces Fiscal 2019 First-Quarter Financial Results; Re-Affirms Adjusted Guidance For Fiscal 2019 PR Newswire
Nov-06-18 06:54AM  Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products PR Newswire
Nov-05-18 08:20AM  Investor Expectations to Drive Momentum within Radian Group, Microvision, Lannett, American Outdoor Brands, Mondelez International, and Ambarella Discovering Underlying Factors of Influence GlobeNewswire
Nov-01-18 06:46AM  Lannett Enters Into Distribution Agreement For Vardenafil Hydrochloride Tablets PR Newswire +8.74%
06:31AM  Lannett To Report Fiscal 2019 First-Quarter Financial Results, Host Conference Call On Wednesday, November 7 PR Newswire
Oct-29-18 10:31AM  Lannett (LCI) Q1 Earnings Preview: What's in the Cards? Zacks
Oct-26-18 02:05PM  SHAREHOLDER ALERT: LCI CBS QRTEA USAT COCP ALNY CHGG JT DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:42AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Lannett Company, Inc. (LCI) and Lead Plaintiff Deadline - October 26, 2018 ACCESSWIRE
Oct-25-18 05:10PM  OCTOBER 26, 2018 INVESTOR DEADLINE: Kaskela Law LLC Files Class Action Against Lannett Company, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Before Deadline ACCESSWIRE
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages. It also provides its products for various medical indications comprising cholesterol, muscle spasm, pain management, irritable bowel, antipsychosis, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, migraine, bronchospasms, and gallstone. In addition, the company manufactures active pharmaceutical ingredients. It markets its products under the Lipitor, Lioresal, Bentyl, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Concerta, Toprol-XL, Prilosec, Ditropan, Protonix, Imitrex, Brethine, and Actigall brands to generic pharmaceutical and private label distributors, drug wholesalers, chain drug retailers, mail-order pharmacies, other pharmaceutical manufacturers, managed care and health maintenance organizations, hospital buying groups, and governmental entities. The company has supply and development agreements with Jerome Stevens Pharmaceuticals, Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, and Aralez Pharmaceuticals. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FARBER JEFFREYDirectorMay 15Buy5.805,00029,0002,101,054May 15 04:14 PM
Crew Timothy CChief Executive OfficerMay 10Buy6.853,00020,55050,758May 10 04:10 PM
FARBER JEFFREYDirectorMay 09Buy6.8510,00068,5002,096,054May 09 04:19 PM
LEPORE PATRICK GDirectorMay 08Buy7.3225,000183,000142,895May 09 04:21 PM
Crew Timothy CChief Executive OfficerFeb 11Buy8.484,00033,92045,988Feb 11 04:31 PM
Chapman John CDirectorDec 14Buy4.9310,00049,30012,574Dec 17 04:20 PM
LEPORE PATRICK GDirectorDec 13Buy5.1025,000127,50092,895Dec 17 11:14 AM
PAONESSA ALBERT IIIDirectorDec 13Buy5.0710,00050,70040,277Dec 14 11:25 AM
FARBER JEFFREYDirectorDec 12Buy5.3210,00053,2002,086,054Dec 14 11:22 AM
Crew Timothy CChief Executive OfficerNov 09Buy5.352,00010,70041,988Nov 13 08:55 AM
LEPORE PATRICK GDirectorAug 31Buy5.3425,000133,50067,895Sep 04 04:19 PM
Crew Timothy CChief Executive OfficerAug 29Buy5.512,00011,02038,250Aug 30 08:39 AM